Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Poll






Jan 13, 2014

Wall Street Losers

GEN recently published a list of the top 10 worst stock performers of 2013—the 10 biotech, pharma, tools/tech, and services (CROs) company stocks whose prices fell the most during the past year. Which of the firms on this list do you think could turn things around in the near future?

Which of our 10 Wall Street Losers do you think is most likely to recuperate and go back up in value?

Amarin
 
  8.6%
Amicus Therapeutics
 
  6.5%
Ariad Pharmaceuticals
 
  40.3%
Aveo Oncology
 
  13.7%
BG Medicine
 
  7.2%
GTx
 
  5.0%
Pernix Therapeutic Holdings
 
  2.9%
Prima BioMed
 
  7.2%
Vical
 
  5.8%
XTL Biopharmaceuticals
 
  2.9%



Related content